Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne C Moorman

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Hepatitis A and B vaccination practices for ambulatory patients infected with HIVEllen M Tedaldi, Rose K Baker, Anne C Moorman, et al.
Plos One|June 7, 2019
Underreporting of Hepatitis B and C virus infections - Pennsylvania, 2001-2015Henry Roberts, Sameh W Boktor, Kirsten Waller, et al.
Journal of Hepatology|May 5, 2015
Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010Robert D Allison, Xin Tong, Anne C Moorman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2006
Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient studyFrank J Palella, Rose K Baker, Anne C Moorman, et al.
Annals of Internal Medicine|April 16, 2003
Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strataFrank J Palella, Maria Deloria-Knoll, Joan S Chmiel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiencyKenneth A Lichtenstein, Carl Armon, Kate Buchacz, et al.
Vaccine|December 28, 2013
Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility--Virginia, 2010Thomas John Bender, Umid Sharapov, Okey Utah, et al.
AIDS (London, England)|October 9, 2002
Prevalence and clinical correlates of HIV viremia ('blips') in patients with previous suppression below the limits of quantificationPeter A Sklar, Douglas J Ward, Rose K Baker, et al.
Annals of Internal Medicine|May 21, 2008
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003Pragna Patel, Debra L Hanson, Patrick S Sullivan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2003
Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapyEllen M Tedaldi, Rose K Baker, Anne C Moorman, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Hepatitis A and B vaccination practices for ambulatory patients infected with HIVEllen M Tedaldi, Rose K Baker, Anne C Moorman, et al.
Plos One|June 7, 2019
Underreporting of Hepatitis B and C virus infections - Pennsylvania, 2001-2015Henry Roberts, Sameh W Boktor, Kirsten Waller, et al.
Journal of Hepatology|May 5, 2015
Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010Robert D Allison, Xin Tong, Anne C Moorman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2006
Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient studyFrank J Palella, Rose K Baker, Anne C Moorman, et al.
Annals of Internal Medicine|April 16, 2003
Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strataFrank J Palella, Maria Deloria-Knoll, Joan S Chmiel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiencyKenneth A Lichtenstein, Carl Armon, Kate Buchacz, et al.
Vaccine|December 28, 2013
Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility--Virginia, 2010Thomas John Bender, Umid Sharapov, Okey Utah, et al.
AIDS (London, England)|October 9, 2002
Prevalence and clinical correlates of HIV viremia ('blips') in patients with previous suppression below the limits of quantificationPeter A Sklar, Douglas J Ward, Rose K Baker, et al.
Annals of Internal Medicine|May 21, 2008
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003Pragna Patel, Debra L Hanson, Patrick S Sullivan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2003
Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapyEllen M Tedaldi, Rose K Baker, Anne C Moorman, et al.
Pageof 9